The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
IT Officials Are Finding Efficiencies Across Cloud, Data Networks
Federal government agencies are utilizing data to integrate capabilities into environments and better deliver on mission.
4m read -
Agentic AI Raises New Security Challenges for Federal Agencies
Agencies are emphasizing risk management and real-time monitoring to keep ahead of potential challenges caused by legitimate and adversary AI agents.
3m read -
Agencies Seek Faster Cloud Adoption, Control Over IT Costs
New tools, faster contracting and automated compliance are helping agencies address challenges in modernizing legacy systems.
2m read -
The Cybersecurity Nightmares Threatening Modern Organizations
Cybersecurity leaders examine the hidden threats facing organizations, from shadow AI and legacy systems to alert fatigue, analyst burnout and emerging AI risks.
17m watch
